Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM weekly movers: PetroNeft Resources set to sell Russian assets

AIM movers: Vela Technologies portfolio gain and Scotgold Resources fundraising

Gfinity seeks more funding

Oxford Metrics already on course for full year forecast

AIM movers: Genedrive test approval and ex-dividends

AdEPT Technology agrees bid from better-funded rival

Songtradr snaps up music streaming technology company 7digital

AIM movers: URU Metals discovers higher grade and Sosandar raises cash

AIM movers: Zinc Media momentum and Bens Creek selling

AIM movers: Pressure Technologies contract and IOG admits Southwark well uncommercial

Aquis weekly movers: S-Venture directors share buying

AIM weekly movers: Vast Resources share price trebles

AIM movers: Conroy Gold intersections and Petro Matad slumps on fundraising

AIM movers: Immotion cash return and ex-dividends

Why companies left AIM in December

Additional FDA approval for Polarean Imaging diagnostic product

AIM movers: Pathfinder Minerals option exercised and Orcadian Energy funding

New AIM admission: Celsius Resources Ltd

AIM movers: Vast Resources increases production and Nicola Foulston ousted at RBG Group

Strong fourth quarter for Porvair

AIM movers: Online Blockchain Rocky Horror NFTs and Rosslyn Data ARR improves

Hargreaves Services at a discount

Bestway builds stake in J Sainsbury

Aquis weekly movers: Chris Akers increases Asimilar stake

AIM weekly movers: Inspecs share price recovery

AIM movers: Sovereign Metals drilling release expected and Alpha Growth NAV decline

Inspecs sees improvement and ex-dividends

Profit upgrade for Time Finance

AIM movers: RUA Life Sciences global partnership and Inland Homes sells land

Dekel Agri-Vision buys cashew minority

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020